Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
Public ClinicalTrials.gov record NCT04539262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2a Study in Participants With Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to characterize the impact of inhaled remdesivir (RDV) on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in participants with early stage coronavirus disease 2019 (COVID-19).
Study identification
- NCT ID
- NCT04539262
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2020 (Actual)
- Primary completion
- Feb 26, 2021 (Actual)
- Completion
- Mar 22, 2021 (Actual)
- Last update posted
- Mar 3, 2022
2020 – 2021
United States locations
- U.S. sites
- 28
- U.S. states
- 8
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Institute for Liver Health | Mesa | Arizona | 85210 | — |
| The Institute for Liver Health | Tucson | Arizona | 85712 | — |
| Franco Felizarta, MD | Bakersfield | California | 93301 | — |
| Aurora FDRC Inc. | Costa Mesa | California | 92627 | — |
| Elevated Health | Huntington Beach | California | 92648 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Western Clinical Research | Placentia | California | 92870 | — |
| UC Davis Health/Medical Center | Sacramento | California | 95817 | — |
| Bradenton Research Center, Inc. | Bradenton | Florida | 34205 | — |
| Integrity Clinical Research, LLC | Doral | Florida | 33166 | — |
| Holy Cross Hospital | Fort Lauderdale | Florida | 33308 | — |
| Research in Miami, Inc. | Hialeah | Florida | 33013 | — |
| Evolution Clinical Trials, Inc. | Hialeah Gardens | Florida | 33016 | — |
| Optimus U Corporation | Miami | Florida | 33125 | — |
| L & C Professional Medical Research Institute | Miami | Florida | 33144 | — |
| Westchester Research Center at Westchester General Hospital | Miami | Florida | 33155 | — |
| MedBio Trials | Miami | Florida | 33180 | — |
| Nuovida Research Center, Corp | Miami | Florida | 33186 | — |
| IMIC Inc | Palmetto Bay | Florida | 33157 | — |
| Triple O Research Institute, PA | West Palm Beach | Florida | 33401 | — |
| Family Care Research | Boise | Idaho | 83704 | — |
| CTU Covid Research Center | New Orleans | Louisiana | 70112 | — |
| STAT Research | Vandalia | Ohio | 45066 | — |
| Inquest Clinical Research | Baytown | Texas | 77521 | — |
| DFW Clinical Research | Dallas | Texas | 75234 | — |
| Baylor Research Institute | Dallas | Texas | 75246 | — |
| PCP for Life-Tidwell | Houston | Texas | 77093 | — |
| Providence Regional Medical Center Everett | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04539262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04539262 live on ClinicalTrials.gov.